Swiss pharma Novartis today announced the largest manufacturing investment in its history, revealing plans for a $700m (€486.5m) biotech facility to be built alongside its new solid dose plant in the low cost, high quality biopharma hub of Singapore.
GlaxoSmithKline (GSK) is planning to strip itself down closer to
the bare bones of the business through further outsourcing and
offshoring, with hopes of making itself into a lean, mean, pharma
Sigma-Aldrich continued its strong year with both revenues and
pre-tax profits showing strong double-digit growth in the third
quarter predicting it will break the $2bn (€1.4bn) revenue mark
We've all cringed at stories of people dumping their partners via
text message but in the world of business, Pfizer seems to have
taken things to a new level when its Exubera partners were
allegedly left to find out the product...
Growing demand has prompted tableting specialist Meldex
International, formerly BioProgress, to launch a new sales and
distribution hub in Germany, with the UK firm also announcing a new
manufacturing contract for its XGel film.
Catalent Pharma Solutions, the firm born from the spin out of
Cardinal Health's contract manufacturing business, is reorganising
its production facilities with an expansion of its UK site and the
divestiture of some of its French...
Sontra Medical has announced its intention to merge with Echo
Therapeutics in a bid to create a company with a powerful
transdermal drug delivery offering, and steadying Sontra's rickety
Johnson & Johnson (J&J) has awarded Canadian contract
manufacturer Draxis a new supply contract large enough to warrant
the construction of a new facility and an expansion of its
workforce by one fifth.
In the latest phase of growth at chemical firm SAFC's flagship high
potency active pharmaceutical ingredients (HPAPIs) facility in
Madison, Wisconsin, the site will be treated to another
multi-million dollar expansion and new...
New research has branded pharmaceutical manufacturers in India as
being responsible for the release of substantial and worrying
amounts of active pharmaceutical ingredients (APIs) into the
GlaxoSmithKline (GSK) and Merck Sharp & Dohme (MSD) have made
further moves in their plans to boost their presence in Singapore,
a region growing in popularity for biopharmaceutical research and
The Medical House (TMH) has sold its SQ-PEN needle-free insulin
injector business as it moves away from supplying the product to
private individuals to focus more on its drug delivery systems
German pharma firm Stada has acquired Russian pharmaceuticals group
Makiz in a deal worth up to €135m, giving the company a sturdy
foothold in the growing Russian market and enhanced in-house
The latest twists and turns in the Inyx Inc. bankruptcy saga
include an attempted power seize by its creditor, fraud allegations
thrown around courtrooms and in the media, the resignation of Inyx'
accountants, and increasing...
A novel spring-powered inhaler system to deliver the blockbuster
COPD (chronic obstructive pulmonary disease) treatment Spiriva
(tiotropium) has successfully completed the EU approval process,
paving the way for its introduction into...
Rentschler Biotechnologie has completed the first phase of a €50m
expansion of its biomanufacturing capacity with the launch of two
new bioreactors aimed at making protein-based drugs for biopharma